Alger Funds · net assets $75.4M · 55 holdings as of July 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 93.4% · STIV: 6.6%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $201K | $150K | $3.98M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $960K | $1.12M | $977K |
| Net realized gain (non-derivative) | $307K | $560K | $10M |
| Net unrealized appreciation (non-derivative) | $1.21M | $5.74M | $-4.5M |
The three months of the reporting period, as filed; month 3 ends July 31, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Dreyfus Treasury Obligations Cash Management STIV | $4.91M | 6.51% |
| Impulse Dynamics Ireland EC | $3.22M | 4.27% |
| Merck & Company Inc EC | $3.15M | 4.18% |
| Welltower Inc EC | $3.1M | 4.12% |
| Johnson & Johnson EC | $3.06M | 4.06% |
| Thermo Fisher Scientific Inc EC | $3.01M | 4.00% |
| Bruker Corp EC | $3M | 3.98% |
| Illumina Inc EC | $2.98M | 3.95% |
| Cvs Health Corp EC | $2.77M | 3.67% |
| Unitedhealth Group Inc EC | $2.72M | 3.61% |
| Teva Pharmaceutical Industries Ltd EC | $2.66M | 3.53% |
| Eli Lilly & Company EC | $2.48M | 3.29% |
| Abbott Laboratories EC | $2.21M | 2.93% |
| 10x Genomics Inc EC | $1.7M | 2.26% |
| Novo Nordisk A/s EC | $1.69M | 2.24% |
| Repligen Corp EC | $1.67M | 2.21% |
| Royalty Pharma PLC EC | $1.46M | 1.94% |
| Centene Corp EC | $1.44M | 1.91% |
| Incyte Corp EC | $1.4M | 1.86% |
| Pennant Group Inc (the) EC | $1.38M | 1.83% |
| Arrowhead Pharmaceuticals Inc EC | $1.37M | 1.81% |
| Guardant Health Inc EC | $1.36M | 1.81% |
| Vertex Pharmaceuticals Inc EC | $1.35M | 1.80% |
| Corteva Inc EC | $1.24M | 1.65% |
| Abivax Sa EC | $1.22M | 1.61% |
| Amgen Inc EC | $1.08M | 1.43% |
| Encompass Health Corp EC | $1.07M | 1.41% |
| Abbvie Inc EC | $1.05M | 1.40% |
| Sandoz Group Ag EC | $953K | 1.26% |
| Adaptive Biotechnologies Corp EC | $827K | 1.10% |
| Dianthus Therapeutics Inc EC | $798K | 1.06% |
| Artivion Inc EC | $727K | 0.97% |
| Cardinal Health Inc EC | $716K | 0.95% |
| Waters Corp EC | $711K | 0.94% |
| Irhythm Holdings Inc EC | $710K | 0.94% |
| Biogen Inc EC | $701K | 0.93% |
| Butterfly Network Inc EC | $695K | 0.92% |
| American Healthcare REIT Inc EC | $684K | 0.91% |
| Twist Bioscience Corp EC | $679K | 0.90% |
| Roivant Sciences Ltd EC | $667K | 0.89% |
| Spyre Therapeutics Inc EC | $661K | 0.88% |
| Natera Inc EC | $646K | 0.86% |
| Ligand Pharmaceuticals Inc EC | $616K | 0.82% |
| Moderna Inc EC | $588K | 0.78% |
| Erasca Inc EC | $586K | 0.78% |
| Acadia Healthcare Company Inc EC | $455K | 0.60% |
| Oscar Health Inc EC | $419K | 0.56% |
| Revolution Medicines Inc EC | $358K | 0.47% |
| Cogent Biosciences Inc EC | $341K | 0.45% |
| Impulse Dynamics Ireland EC | $285K | 0.38% |
| Heartflow Inc EC | $277K | 0.37% |
| Biomarin Pharmaceutical Inc EC | $209K | 0.28% |
| Janus Living Inc EC | $73.1K | 0.10% |
| Edwards Lifesciences Corp EC | $63.3K | 0.08% |
| Tolero Dcr EC | — | 0.00% |
Loading...
